Global Veterinary Diagnostics Market - By Products, By Animal Types & Geography - Trends & Forecasts- (2016 - 2021)

  • ID: 2970389
  • Report
  • Region: Global
  • 117 pages
  • Mordor Intelligence
1 of 4
Global Market For Diagnostics In Veterinary Healthcare Expected To Reach A Market Size Of $2.02 Billion By 2019


  • Abaxis
  • Henry Schein
  • Idexx
  • Neogen Corporation
  • Pfizer
  • Thermo Fisher Scientific
  • MORE
The global market for diagnostics in veterinary healthcare is valued at an estimated $1.59 billion in 2014.

Ever-rising demand for animal protein and stricter regulations concerning food safety will propel the market for diagnostics in animal healthcare to grow at a healthy CAGR of 4.6 % to reach a market size of $2.02 billion by 2019.

Diagnostics provide tools for effective and rapid testing to undertake preventative or remedial measures for the health of the animal population. For instance, lateral flow and other rapid tests are used in veterinary medicine to test commercial livestock (large animals – cows, poultry, sheep, pigs, etc.) and household pets (cats, dogs, etc.) to test for the presence of a variety of medical conditions caused by bacteria, viruses, allergies, fertility issues and diabetes.

Developing regions in Asia-pacific and Africa are expected to form a new revenue pocket in the market, with India, China and Brazil constituting a majority of market growth over the next decade.

This report does not include the food safety testing segment that concerns testing animals that are about to enter (about to be slaughtered) or have entered the food chain.

Global veterinary Diagnostics market is segmented by type of products i.e. Enzyme linked Immuno Sorbent Assay(ELISA), Rapid Immuno Migration (RIM), Diagnostic imaging, Ultrasound Imaging, etc. The market is additionally segmented by type of animals into companion animals and farm animals. The report also covers the market by geography, studying diagnostics in North America, Asia-Pacific, Europe and the rest of world.

Pfizer (U.S.), Merck (U.S.), Sanofi-Aventis (France), Bayer HealthCare (Germany), Virbac (France), Novartis (Switzerland), Boehringer Ingelheim (Germany), Heska Corporation (U.S.), Bioniche Animal Health Canada, Inc. (Canada), and Ceva (France) are the key players in the global animal diagnostics market.

What makes our report unique?

1) In-depth analysis of current market trends and future forecasts of the market based on different products and services available for diagnostics in animal healthcare.
2) We provide the longest possible market segmentation based on diseases that afflict animals, animal species and by geography.
3) The comprehensive competitive landscape section in the report provides information about major players in the market, their market shares and recent developments.
Note: Product cover images may vary from those shown
2 of 4


  • Abaxis
  • Henry Schein
  • Idexx
  • Neogen Corporation
  • Pfizer
  • Thermo Fisher Scientific
  • MORE
1.1 Market Definition
1.2 Market Recent Trends

2. Market Analysis
2.1 Market Animal Health Products
2.2 Animal medicines vs human Medicines

3. Market Dynamics
3.1 Market Drivers
3.1.1 Increase in pet ownership
3.1.2 Improved Nutrition
3.1.3 Intensifying consumer focus on food safety
3.1.4 Greater Livestock production
3.1.5 Increasing Zoonotic and Foodborne Diseases
3.2 Market Constraints
3.2.1 Scarcity of arable land and water
3.2.2 Increased competition for cultivated land
3.2.3 Cost effective production
3.3 . Porter’s Five Force Analysis
3.3.1 Threat of New Entrant
3.3.2 Internal Rivalry
3.3.3 Buyer bargaining power
3.3.4 Supplier bargaining power
3.3.5 Threat of substitutes

4.Global Veterinary Diagnostic Market Segmentation
4.1 Global Veterinary Diagnostic market, By products
4.1.1 Introduction
4.1.2 Immunodiagnostic Tests Enzyme linked immuno-sorbent assay (ELISA) Rapid Immuno Migration (RIM™) Agar gel immuno-diffusion (AGID)
4.1.3 Molecular Diagnostic Tests Polymerase Chain Reaction (PCR) Diagnostic Imaging Ultrasound Imaging Mri Scanning
4.2 Global Veterinary Diagnostic Market, By species
4.2.1 Companion Animals Dogs Cats Horses
4.2.2 Farm animal Cattle Swine Poultry Fish Sheep
4.3 Global Veterinary DiagnosticMarket Segmentation, By Geography
4.3.1 North America US Mexico Canada
4.3.2 Europe France Italy Germany Spain Sweden Rest of Europe
4.3.3 Asia-Pacific India China Japan Rest of Asia-Pacific

5. Competitive landscape
5.1 Major players in the market
5.2 Mergers and acquisitions
5.3 New product launches
5.4 Agreement, Collaborations and Partnerships
5.5 Recommendations for New players
5.6 Recommendations for Existing players

6. Company profiles
6.1 Zoetis animal healthcare
6.1.1 Financial Overview
6.1.2 Business overview
6.1.3 Business strategies
6.2 Abaxis, Inc
6.2.1 Financial Overview
6.2.2 Business overview
6.2.3 Business strategies
6.3 Neogen Corporation
6.3.1 Financial Overview
6.3.2 Business overview
6.3.3 Business strategies
6.4 Heska corporation
6.4.1 Financial Overview
6.4.2 Business overview
6.4.3 Business strategies
6.5 IDEXX Laboratories
6.5.1 Financial Overview
6.5.2 Business overview
6.5.3 Business strategies
6.6 Qiagen
6.6.1 Financial Overview
6.6.2 Business overview
6.6.3 Business strategies
6.7 Virbac
6.7.1 Financial Overview
6.7.2 Business overview
6.7.3 Business strategies
6.8 Prionics
6.8.1 Financial Overview
6.8.2 Business overview
6.8.3 Business strategies
6.9 Biochek
6.9.1 Financial Overview
6.9.2 Business overview
6.9.3 Business strategies
6.10 IDVet
6.10.1 Financial Overview
6.10.2 Business overview
6.10.3 Business strategies
6.11 Thermo Fisher Scientific Inc.
6.11.1 Financial Overview
6.11.2 Business overview
6.11.3 Business strategies

7. Appendix
Note: Product cover images may vary from those shown
3 of 4


4 of 4
- Abaxis
- Biochek
- Henry Schein
- Heska Corporation
- IDVet
- Idexx
- Neogen Corporation
- Patterson Companies
- Pfizer
- Qiagen
- Thermo Fisher Scientific
- VCA Antech
- Virbac
- Zoetis
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown